Saswati Chakladar

Title: Saswati Chakladar: Innovator in Pharmaceutical Chemistry

Introduction

Saswati Chakladar is a notable inventor based in Delhi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used to treat various medical conditions. His work has the potential to impact the treatment of several inflammatory diseases.

Latest Patents

Saswati Chakladar holds a patent for "Substituted indazoles as inhibitors of phosphodiesterase type-IV." This invention relates to isoxazoline derivatives that serve as selective inhibitors of phosphodiesterase (PDE) type IV. The compounds disclosed in this patent can be beneficial in treating a range of conditions, including CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis, and other inflammatory diseases, particularly in humans. The patent also includes processes for preparing these compounds and pharmaceutical compositions containing them.

Career Highlights

Saswati Chakladar is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex health issues.

Collaborations

Saswati has collaborated with notable colleagues, including Venkata Poornapragnacharyulu Palle and Sarala Balachandran, who contribute to the research and development efforts in their field.

Conclusion

Saswati Chakladar's contributions to pharmaceutical chemistry, particularly through his patent on PDE type IV inhibitors, highlight his role as an innovator in the medical field. His work has the potential to improve the quality of life for many individuals suffering from inflammatory diseases.